Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe

Barkholt, L.; Bregni, M.; Remberger, M.; Blaise, D.; Peccatori, J.; Massenkeil, G.; Pedrazzoli, P.; Zambelli, A.; Bay, J.; Francois, S.; Martino, R.; Bengala, C.; Brune, M.; Lenhoff, S.; Porcellini, A.; Falda, M.; Siena, S.; Demirer, TANER; Niederwieser, D.; Ringden, O.

doi:10.1093/annonc/mdl086

Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe

Atıf İçin Kopyala

Barkholt L., Bregni M., Remberger M., Blaise D., Peccatori J., Massenkeil G., ...Daha Fazla

ANNALS OF ONCOLOGY, cilt.17, sa.7, ss.1134-1140, 2006 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 17 Sayı: 7
Basım Tarihi: 2006
Doi Numarası: 10.1093/annonc/mdl086
Dergi Adı: ANNALS OF ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1134-1140
Anahtar Kelimeler: allogeneic stem cell transplantation, antitumour effect, reduced intensity conditioning, renal cell carcinoma, GRAFT-VERSUS-LEUKEMIA, BONE-MARROW-TRANSPLANTATION, ENDOTHELIAL GROWTH-FACTOR, STATISTICAL-METHODS, HOST-DISEASE, CANCER, CHEMOTHERAPY, RECIPIENTS, THERAPY, TUMOR
Ankara Üniversitesi Adresli: Evet

Özet

Background: An allogeneic antitumour effect has been reported for various cancers. We evaluated the experience of allogeneic haematopoietic stem cell transplantation (HSCT) for renal cell carcinoma (RCC) in 124 patients from 21 European centres.